Yoga Program for Lung Cancer Patients and Caregivers
The goal of this behavioral research study is to learn the opinion of patients and their caregivers about a couple-based Hatha Yoga program (Group 1) during treatment for cancer. Researchers also want to learn the effect of this program on lung function, distress, biological function, and quality of life. For comparison purposes, there will also be a group of participants (Group 2) that does not take part in this program. You and your caregiver/family member will have about a 50/50 chance of being assigned to each group. The groups are randomly assigned, but it is also based on other factors such as your age and the status of the disease.
Checked against the public recordLast updated Feb 16, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- M.D. Anderson Cancer Center
- Interventions being studied
- Behavioral: Hatha Yoga; Behavioral: Questionnaires; Other: Walk Test
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. Patients with lung or esophageal cancer stages I through IIIB who are going to receive at least 5 weeks of daily thoracic radiation therapy with or without chemotherapy in the Department of Radiation Oncology at M. D. Anderson Cancer Center (MDACC) and have an eligible and consenting family caregiver living with the patient while he/she receives treatment (i.e., adult child, sibling, parent). 2. Patients and caregivers must both be at least 18 years old and able to give informed consent. 3. Patients and caregivers must be able to read, write, and speak English. 4. Patient and caregiver must be willing to be videotaped. Exclusion Criteria: 1. Patients and caregivers who are not oriented to time, place, and person. 2. Patients who have regularly practiced yoga in the year prior to recruitment. 3. Patients who have an ECOG performance status score greater than 2 at time of recruitment.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Texas MD Anderson Cancer CenterHouston, Texas
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 16, 2023. Always confirm current availability with the study team.